Provided by Tiger Trade Technology Pte. Ltd.

Assembly Biosciences

25.91
+0.36001.41%
Post-market: 25.910.00000.00%16:10 EDT
Volume:79.18K
Turnover:2.07M
Market Cap:498.79M
PE:-20.08
High:26.57
Open:25.80
Low:25.80
Close:25.55
52wk High:39.71
52wk Low:16.90
Shares:19.25M
Float Shares:10.41M
Volume Ratio:0.58
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2901
EPS(LYR):-0.5461
ROE:-5.66%
ROA:-5.06%
PB:2.51
PE(LYR):-47.45

Loading ...

Assembly Biosciences Announces Expansion of ABI-6250 Clinical Development Into Cholestatic Liver Diseases

GlobeNewswire
·
May 22

Analyst Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target Amid Pipeline Progress and 2028 Cash Runway

TIPRANKS
·
May 14

Assembly Bio to present topline Phase 1a data for HDV entry inhibitor ABI-6250 at EASL 2026

Reuters
·
May 13

Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference

GlobeNewswire
·
May 11

Guggenheim Sticks to Its Buy Rating for Assembly Biosciences (ASMB)

TIPRANKS
·
May 11

Assembly Biosciences posts corporate presentation on antiviral pipeline for herpesviruses, hepatitis B and D

Reuters
·
May 08

Assembly Biosciences Q1 revenue falls, net loss widens

Reuters
·
May 08

Assembly Biosciences Q1 EPS $(0.54) Beats $(0.71) Estimate, Sales $8.213M Miss $9.266M Estimate

Benzinga
·
May 08

Assembly Bio Q1 FY26 net loss narrows to $9.1 million; revenue slips to $8.2 million

Reuters
·
May 08

Assembly Biosciences Q1 EPS USD -0.54

THOMSON REUTERS
·
May 08

Assembly Biosciences Q1 Net Income USD -9.079 Million

THOMSON REUTERS
·
May 08

Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

GlobeNewswire
·
May 08

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 07

Assembly Biosciences Inc expected to post a loss of 57 cents a share - Earnings Preview

Reuters
·
May 05

Assembly Biosciences Price Target Maintained With a $50.00/Share by HC Wainwright & Co.

Dow Jones
·
May 04

Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Artiva Biotherapeutics, Inc. (ARTV) and Emergent Biosolutions (EBS)

TIPRANKS
·
May 04

Assembly Bio highlights positive Phase 1b HSV data for ABI-5366 at ESCMID 2026

Reuters
·
Apr 09

Assembly Biosciences Is Maintained at Buy by Guggenheim

Dow Jones
·
Apr 06

Assembly Biosciences price target raised to $43 from $39 at Guggenheim

TIPRANKS
·
Apr 06

Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan

TIPRANKS
·
Mar 31